Geode Capital Management’s NLS Pharmaceutics NLSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-359
| Closed | -$3.12K | – | 4565 |
|
|
2024
Q2 | $3.12K | Hold |
359
| – | – | ﹤0.01% | 4582 |
|
|
2024
Q1 | $2.61K | Hold |
359
| – | – | ﹤0.01% | 4599 |
|
|
2023
Q4 | $8.47K | Hold |
359
| – | – | ﹤0.01% | 4603 |
|
|
2023
Q3 | $9.92K | Hold |
359
| – | – | ﹤0.01% | 4726 |
|
|
2023
Q2 | $15.8K | Hold |
359
| – | – | ﹤0.01% | 4683 |
|
|
2023
Q1 | $21.7K | Hold |
359
| – | – | ﹤0.01% | 4691 |
|
|
2022
Q4 | $18K | Hold |
359
| – | – | ﹤0.01% | 4781 |
|
|
2022
Q3 | $9K | Hold |
359
| – | – | ﹤0.01% | 4993 |
|
|
2022
Q2 | $8K | Hold |
359
| – | – | ﹤0.01% | 4992 |
|
|
2022
Q1 | $20K | Hold |
359
| – | – | ﹤0.01% | 4930 |
|
|
2021
Q4 | $16K | Hold |
359
| – | – | ﹤0.01% | 4955 |
|
|
2021
Q3 | $35K | Buy |
+359
| New | +$35K | ﹤0.01% | 4812 |
|